General description
Hydroxylurasidone is the most abundant metabolite of lurasidone in urine. Lurasidone, marketed under the trade name Latuda®, is a new atypical antipsychotic developed for the treatment of schizophrenia and episodes of depression in adults with bipolar disorder (manic depression). A certified solution standard suitable for use in LC/MS or GC/MS applications for clinical toxicology, forensic analysis, pharmaceutical research, or urine drug testing.
Legal Information
Latuda is a registered trademark of Dainippon Sumitomo Pharma Co., Ltd.
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
CERILLIANT is a registered trademark of Cerilliant Corporation
This product has met the following criteria to qualify for the following awards: